An analysis of past research conducted by the Salt Lake City-based University of Utah Health John A. Moran Eye Center found cause for further testing to determine if cataracts might someday be ...

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The phase 3 OPTIMIZE trial met both primary efficacy ...

Credit: Getty Images. OCS-01 is a novel, high concentration (15mg/mL), topical formulation of dexamethasone. Once-daily administration of an investigational corticosteroid eye drop (OCS-01) was found ...

Please provide your email address to receive an email when new articles are posted on . A novel preservative-free betamethasone eye drop formulation showed efficacy in preventing inflammation and pain ...

OPTIMIZE (Once-daily Post-ocular surgery Treatment for InflaMmation and paIn to minimiZE drops) is a double-blind, placebo-controlled Phase 3 trial conducted in 25 sites across the US with 241 ...

FRESNO, Calif. (KFSN) -- New technology is bringing clarity to those with blurry vision. EYE-Q is now offering the Light Adjustable Lens to patients who are having cataract surgery. According to Dr.

Most of us expect our eyesight to change gradually over time. Reading the menu may need a little more light, night driving can feel less comfortable, or colours may seem slightly duller than they once ...

A small proof-of-concept study of robotic-assisted cataract surgery reports successful outcomes with no treatment-related ...

FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

Once daily OCS-01 meets primary endpoints demonstrating superior reduction in inflammation and pain vs. vehicle following cataract surgery OPTIMIZE’s results follow the positive and statistically ...